Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamivudine + adefovir versus entecavir in decompensated HBV-related cirrhosis
ChiCTR-TRC-10001012Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hepatitis B (HBV) and Cirrhosis comparing Lamivudine + adefovir combination therapy with Entecavir therapy (2 arms). Primary endpoints: HBV markers, HBV-DNA and 1 more. Started Mar 2010; status: completed.
02
Drugs
lamivudineadefovir dipivoxilentecavir
03
Conditions
hepatitis B (HBV)Cirrhosis
Beyond the preview
Go deeper on ChiCTR-TRC-10001012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10001012.